Renal Cancer - Results from #540

AVEO Oncology Announces Completion of Enrollment in Pivotal Phase 3 TiNivo-2 Study of FOTIVDA® (tivozanib) in Combination with OPDIVO® (nivolumab) in Advanced Renal Cell Carcinoma January 8, 2024

Effects of Purine Metabolism-Related LINC01671 on Tumor Heterogeneity in Kidney Renal Clear Cell Carcinoma. January 8, 2024

Intraoperative Embolization during Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma. January 8, 2024

High Preoperative Plasma Fibrinogen Independently Predicts a Poor Prognosis in Patients with Nonmetastatic RCC. January 8, 2024

Does the VHL polymorphisms rs779805 and rs1642742 affect renal cell carcinoma susceptibility, prognosis and survival in Central European population? January 5, 2024

Genomic Fabrics of the Excretory System's Functional Pathways Remodeled in Clear Cell Renal Cell Carcinoma. January 5, 2024

Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors. January 5, 2024

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial. January 5, 2024

Discontinuation of Immune-oncology Combinations due to Immune-related Adverse Events in Patients With Advanced Renal Cancers. January 4, 2024

Integration of bioinformatics analysis to identify possible hub genes and important pathways associated with clear cell renal cell carcinoma. January 4, 2024

Preserving Renal Function without Compromising Oncological Outcomes: A Comparative Study of Partial and Total Nephrectomies in T3 Stage Renal Cell Carcinoma. January 3, 2024

Papillary Renal Cell Carcinoma: Demographics, Survival Analysis, Racial Disparities, and Genomic Landscape. January 3, 2024

Comparison of aggressiveness in central versus peripheral T1a clear-cell renal cell carcinoma. January 2, 2024

Percutaneous cryoablation of 100 anterior renal tumors: safety and technical success. January 2, 2024

Mesenchymal-Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis. January 1, 2024

Associations between R.E.N.A.L. nephrometry score and survival outcomes in renal tumours. January 1, 2024

Treatment Landscape of Renal Cell Carcinoma. December 29, 2023

Short- and Long-Term Renal Function After Partial Nephrectomy: Comparison of Solitary and Multifocal Renal Masses. December 29, 2023

Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma. December 28, 2023

Functional recovery after partial nephrectomy in a solitary kidney. December 28, 2023

Page 28 of 455